Last10K.com

Therapy Cells Inc (TCEL) SEC Filing 10-Q Quarterly report for the period ending Thursday, March 31, 2011

Therapy Cells Inc

CIK: 1429859 Ticker: TCEL

View differences made from one quarter to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.

Continue

Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Therapy Cells Inc provided additional information to their SEC Filing as exhibits

Ticker: TCEL
CIK: 1429859
Form Type: 10-Q Quarterly Report
Accession Number: 0001683168-19-003217
Submitted to the SEC: Thu Oct 10 2019 12:31:50 PM EST
Accepted by the SEC: Thu Oct 10 2019
Period: Thursday, March 31, 2011
Industry: Wholesale Jewelry Watches Precious Stones And Metals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tcel/0001683168-19-003217.htm